Medtronic Viva Cardiac Resynchronization Therapy-Pacemaker Now Available In Europe

Medtronic, Inc. recently announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P. The Viva CRT-P is not approved for sale in the United States.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news